Establishment of an animal model of breast cancer based on in vivo bioluminescence imaging

Tumor

Volumn 29, Issue 1, 2009, Pages 76-80

  Li, Yan ^a,b   Zhang, Hai Yan ^a   Wang, Zhe ^a   Zhang, Bi Liang ^a,c  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c State Key Laboratory for Respiratory Diseases   (China)

Author keywords

Breast neoplasms; Implanted tumor; Luciferases; Models, animal; Optical in vivo imaging system

Indexed keywords

LIPOFECTAMINE; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; BREAST CANCER; CANCER GROWTH; CANCER RESEARCH; CANCER TRANSPLANTATION; CELL CLONE; CELL GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMAGING SYSTEM; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PLASMID; PROTEIN EXPRESSION; REPORTER GENE; TUMOR XENOGRAFT;

EID: 77953384913     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2009.01.018     Document Type: Article

References (14)

1. CONTAG C H, JENKINS D, CONTAG P R, et al. Use of reporter genes for optical measurements of neoplastic disease in vivo [J]. Neoplasia,2000,2(1-2): 41-52.
2. EDINGER M, CAO Y A, HORNIG Y S, et al. Advancing animal models of neoplasia through in vivo bioluminescence imaging[J]. Eur J Cancer,2002,38(16): 2128-2136.
3. CACERES G, ZANKINA R, ZHU X, et al. Determination of chemotherapeutic activity in vivo by luminescent imaging of luciferase-transfected human tumors [J]. Anticancer Drugs, 2003, 14(7): 569-574.
4. JENKINS D E, OEI Y, HORNIG Y S, et al. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis[J]. Clin Exp Metastasis, 2003, 20 (8):733-744.
5. SCATENA C D, HEPNER M A, OEI Y A, et al. Imaging of bioluminescent LNCaPluc-M6 tumors: a new animal model for the study of metastatic human prostate cancer[J]. Prostate, 2004,59(3): 292-303.
6. + natural killer T cells redirected with bispecific antibody F (ab′) (2) HER2xCD3 [J]. Cancer Res,2002,62(20):5785-5791.
7. ZEAMARI S, RUMPING G, FLOOT B, et al. In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats[J]. Br J Cancer,2004,90(6): 1259-1264.
8. LUKER G D, BARDILL J P, PRIOR J L, et al. Non-invasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice[J]. J Virol, 2002, 76(23):12149-12161.
9. COOK S H, GRIFFIN D E. Luciferase imaging of a neurotropic viral infection in intact animals[J]. J Virol,2003, 77(9):5333-5338.
10. SMITH P G, AKLEV F, FERNANDEZ M, et al. Herpesvirus saimiri-based vector biodistribution using noninvasive optical imaging[J]. Gene Ther,2005, 12(19):1465-1476
11. CIANA P, RAVISCIONI M, MUSSI P, et al. In vivo imaging of transcriptionally active estrogen receptors[J]. Nat Med,2003, 9 (1): 82-86.
12. EDINGER M, SWEENEY T J, TUCKER A A, et al. Non-invasive assessment of tumor cell proliferation in animal models [J]. Neoplasia, 1999,1(4):303-310.
13. SWEENEY T J, MAILANDER V, TUCKER A A, et al. Visualizing the kinetics of tumor cell clearance in living animals[J]. Proc Natl Acad Sci USA, 1999,96(21): 12044-12049.
14. SUSAN B, MARC M, KEITH S, et al. The expression level of luciferase within tumour cells can alter tumour growth upon in vivo bioluminescence imaging [J]. Luminescence,2007, 22(3):221-228.